Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Johnson & Johnson has reported record sales of $16.2 billion for the first quarter of 2008, an increase of 7.7%, as compared to the sales of the first quarter of 2007.
Subscribe to our email newsletter
For Q1 2008, operational growth was 2.6% and currency contributed 5.1%. Domestic sales were up 2.8%, while international sales increased 13.7%, reflecting operational growth of 2.4% and a positive currency impact of 11.3%. Net earnings and diluted earnings per share were $3.6 billion and $1.26, respectively.
Worldwide consumer segment sales of $4.1 billion for the first quarter represented a 16.2% increase over the same period of 2007 with operational growth of 9.9% and a positive impact from currency of 6.3%. Domestic sales increased 11.7%, while international sales increased 20.2% (8.3% from operations and 11.9% from currency).
Worldwide pharmaceutical segment sales of $6.4 billion for Q1 2008 represented an increase over the same period of 2007 of 3.3% with an operational decline of 0.6% and a positive impact from currency of 3.9%. Domestic sales increased 0.9%, while international sales increased 7.9%, which reflected an operational decline of 3.1% and a positive currency impact of 11%.
Worldwide medical devices and diagnostics segment sales of $5.7 billion for the first quarter of 2008 represented a 7.2% increase over the prior year with operational growth of 1.4% and a positive impact from currency of 5.8%. Domestic sales increased 0.2%, while international sales increased 13.8% (2.6% from operations and 11.2% from currency).